Armbruster Capital Management, Inc. Amgen Inc Transaction History

Armbruster Capital Management, Inc.

$500 Million
Q3 2024

A detailed history of Armbruster Capital Management, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Armbruster Capital Management, Inc. holds 2,472 shares of AMGN stock, worth $692,184. This represents 0.16% of its overall portfolio holdings.

Number of Shares

2,472

Previous 2,487 0.6%

Holding current value

$692,184

Previous $777,000 2.45%

% of portfolio

0.16%

Previous 0.16%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$309.38 - $337.38 $4,640 - $5,060	-15 Reduced 0.6%	2,472 $796,000
Q2 2024 Jul 29, 2024	BUY	$262.75 - $319.31 $18,918 - $22,990	72 Added 2.98%	2,487 $777,000
Q1 2024 May 07, 2024	SELL	$268.87 - $324.56 $16,132 - $19,473	-60 Reduced 2.42%	2,415 $686,000
Q1 2023 May 09, 2023	SELL	$225.79 - $275.2 $9,031 - $11,008	-40 Reduced 1.59%	2,475 $598,000
Q2 2022 Aug 01, 2022	SELL	$230.71 - $256.74 $17,303 - $19,255	-75 Reduced 2.9%	2,515 $612,000
Q1 2022 May 05, 2022	BUY	$219.27 - $242.57 $7,674 - $8,489	35 Added 1.37%	2,590 $626,000
Q1 2021 Apr 29, 2021	SELL	$221.91 - $258.6 $27,738 - $32,325	-125 Reduced 4.66%	2,555 $636,000
Q1 2020 May 08, 2020	SELL	$182.24 - $241.7 $91,120 - $120,850	-500 Reduced 15.72%	2,680 $543,000
Q2 2019 Jul 18, 2019	SELL	$166.7 - $195.41 $23,338 - $27,357	-140 Reduced 4.22%	3,180 $586,000
Q2 2018 Jul 30, 2018	SELL	$166.05 - $186.51 $53,136 - $59,683	-320 Reduced 8.79%	3,320 $613,000
Q1 2018 Apr 18, 2018	SELL	$169.43 - $198.0 $16,943 - $19,800	-100 Reduced 2.67%	3,640 $621,000
Q4 2017 Feb 02, 2018	SELL	$168.79 - $188.59 $16,879 - $18,859	-100 Reduced 2.6%	3,740 $650,000
Q3 2017 Nov 08, 2017	BUY	$167.29 - $191.0 $642,393 - $733,440	3,840	3,840 $716,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Armbruster Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Armbruster Capital Management, Inc. with notifications on news.

Account

Armbruster Capital Management, Inc. Amgen Inc Transaction History